UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy

Using a novel strategy, team finds tumors that can be imaged by FAC PET

2012-12-11

(Press-News.org) Liposarcoma, the most common type of sarcoma, is an often lethal form of cancer that develops in fat cells. It is particularly deadly, in part, because the tumors are not consistently visible with positron emission tomography (PET) scans that use a common probe called FDG and because they frequently do not respond to chemotherapy.

Now, using a strategy that tracks cancer cells' consumption of nucleosides, a team of researchers at UCLA's Jonsson Comprehensive Center has identified a group of liposarcoma tumors that can be imaged by PET scanning using a tracer substance known as FAC. Furthermore, they have found that these tumors are sensitive to chemotherapy.

The team's findings are published online in the journal Cancer Discovery and will appear in an upcoming print edition.

Led by Jonsson Cancer Center researcher Heather Christofk, an assistant professor of molecular and medical pharmacology at UCLA, the scientists employed a metabolomic strategy that detected nucleoside salvage activity in liposarcoma cells taken from patient samples, cells grown in the laboratory and cells grown in mouse models. The nucleoside activity was visible using PET with the UCLA-developed FAC probe (FAC PET), which measures the activity of the DNA salvage pathway, a fundamental cell biochemical pathway that acts as a sort of recycling mechanism to help with DNA replication and repair.

FAC was created by slightly altering the molecular structure of the standard chemotherapy drug gemcitabine, and in the current study, the UCLA research team discovered that the liposarcoma cells with high nucleoside salvage activity were sensitive to gemcitabine chemotherapy.

In clinical practice, this strategy might be used to identify liposarcoma patients, at the time of diagnosis, who would respond well to gemcitabine chemotherapy, saving time on other treatments and possibly extending the lives of this sub-group of patients.

"It was a satisfying study because it has translational potential for liposarcoma patients now — and this is a deadly disease," Christofk said. "Our metabolomic strategy is also generalizable to treatment strategies for other cancers, and that is something we hope to do."

The study was a collaboration between basic scientists and clinicians, following the translational paradigm of bench-to-bedside discoveries.

"This was an outstanding transdisciplinary project between a diverse group of physician scientists and basic scientists that translates molecular oncology from the laboratory to the clinic in a rapid and clinically relevant manner," said Dr. Fritz Eilber, an associate professor of surgery and of molecular and medical pharmacology at UCLA and an investigator on the study. "The findings from this work can be used to directly impact the care of patients with this morbid and lethal malignancy."

### The research was supported in part by NIH grant P50CA0863062. Christofk is a Damon Runyon–Rachleff Innovation awardee, supported in part by the Damon Runyon Cancer Research Foundation, the Searle Scholars Program, the NIH Director's New Innovator Award (DP2 OD008454-01) and the Caltech/UCLA Nanosystems Biology Cancer Center (NCI U54 CA151819).

UCLA's Jonsson Comprehensive Cancer Center has more than 240 researchers and clinicians engaged in disease research, prevention, detection, control, treatment and education. One of the nation's largest comprehensive cancer centers, the Jonsson Center is dedicated to promoting research and translating basic science into leading-edge clinical studies. In July 2012, the Jonsson Cancer Center was once again named among the nation's top 10 cancer centers by U.S. News & World Report, a ranking it has held for 12 of the last 13 years.

For more news, visit the UCLA Newsroom and follow us on Twitter.

ELSE PRESS RELEASES FROM THIS DATE:

Glaucoma study could inspire e-reader apps

2012-12-11

Rockville, MD — Better strategies are needed to help glaucoma patients cope with difficulty reading. According to a new scientific study published in Investigative Ophthalmology & Visual Science, adults with glaucoma read slower when reading silently for long periods of time and are more likely to have their reading speed decrease over time, possibly a result of reading fatigue. Technological solutions such as e-readers – and the many apps being created for them – could help. "Right now, so many products are available for presenting reading material in a variety of formats," ...

Citizen science more than a century later: Ordinary people go online to track Gulf oil spill

2012-12-11

WASHINGTON—In the summer of 1854 a doctor named John Snow tracked London's deadly outbreak of cholera to contaminated water coming from a public well—the now famous Broad Street pump. But Snow's observations had to wend their way through the annals of science and took years to make an impact on the public health. Now, more than a century later, ordinary people can go online and report observations about public health problems and disasters in real time. In a just-published study a researcher at the George Washington University School of Public Health and Health Services ...

Drug helps women who stop smoking keep weight off

2012-12-11

A medication being tested to help smokers kick the habit also may help avoid the weight gain that is common after quitting but only in women, according to a study published in the December issue of Biological Psychiatry. This is the first medication shown to reduce weight gain for up to one year in women smokers who quit. Naltrexone — an opioid blocker that can dampen the desire for alcohol, heroin and nicotine, as well as the pleasures of eating — helped men quit smoking. It improved their quit rates after three months of treatment in a large controlled trial, from 17 ...

A new tool for secret agents -- and the rest of us

2012-12-11

PASADENA, Calif.—A secret agent is racing against time. He knows a bomb is nearby. He rounds a corner, spots a pile of suspicious boxes in the alleyway, and pulls out his cell phone. As he scans it over the packages, their contents appear onscreen. In the nick of time, his handy smartphone application reveals an explosive device, and the agent saves the day. Sound far-fetched? In fact it is a real possibility, thanks to tiny inexpensive silicon microchips developed by a pair of electrical engineers at the California Institute of Technology (Caltech). The chips generate ...

Researcher finds gender differences in seasonal auditory changes

2012-12-11

ATLANTA – Auditory systems differ between sexes in sparrows depending on the season, a Georgia State University neuroscientist has found. The work adds to our knowledge of how the parts of the nervous system, including that of humans, are able to change. Megan Gall, a post-doctoral researcher with Georgia State's Neuroscience Institute, tested the peripheral auditory systems of male and female house sparrows, comparing the hearing of each gender during non-breeding seasons and breeding seasons. Gall measured frequency selectivity – the ability to tell sounds that are ...

Pharmacy researcher finds most popular weight-loss drug strongly alters other drug therapies

2012-12-11

KINGSTON, R.I.— December 10, 2012 – A University of Rhode Island researcher has discovered that the weight-loss drug orlistat, known by the brand names Xenical and Alli, inhibits a key enzyme that may lead to "severe toxicity of internal organs such as the liver and kidney." The inhibition is irreversible and can be caused by a low level of the drug. Professor Bingfang Yan's study funded by the National Institutes of Health, also found that the drug alters efficacy of medicines, and particularly limits the effectiveness of some anti-cancer drugs. Part of the research ...

Novel drug therapy targets aggressive form of non-Hodgkin's lymphoma

2012-12-11

NEW YORK (Dec. 10, 2012) -- Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell – DLBCL (ABC-DLBCL), remains a major therapeutic challenge. An international research team, led by two laboratories from Weill Cornell Medical College, has developed a new experimental drug therapy to target this aggressive form of lymphoma. In the journal Cancer Cell, researchers report the discovery of an experimental small molecule ...

Quantifying corn rootworm damage

2012-12-11

URBANA – Every year farmers spend a lot of money trying to control corn rootworm larvae, which are a significant threat to maize production in the United States and, more recently, in Europe. University of Illinois researchers have been working on validating a model for estimating damage functions. Nicholas Tinsley, a doctoral candidate in crop sciences, has refined a model developed in 2009 by researchers at the University of Wisconsin and in Brescia, Italy, to describe the relationship between root injury caused by these pests and yield loss. He used the equivalent ...

Wayne State researcher finds possible clue to children's early antisocial behavior

2012-12-11

DETROIT - Both nature and nurture appear to be significant factors in early antisocial behaviors of adopted children, a Wayne State University researcher believes. Christopher Trentacosta, Ph.D., assistant professor of psychology in the College of Liberal Arts and Sciences, recently examined data from 361 linked triads (birth mother, adoptive parents, adopted child) in order to assess externalizing behavioral problems such as aggression and defiance when children were 18, 27 and 54 months of age. The triads were part of the Early Growth and Development Study (EGDS), ...

The dark side of kerosene lamps: High black-carbon emissions

2012-12-11

CHAMPAIGN, Ill. — The small kerosene lamps that light millions of homes in developing countries have a dark side: black carbon – fine particles of soot released into the atmosphere. New measurements show that kerosene wick lamps release 20 times more black carbon than previously thought, say researchers at the University of Illinois and the University of California, Berkeley. The group published its findings in the journal Environmental Science and Technology. Black carbon is a hazard for human health and the environment, affecting air quality both indoors and out. ...

Prioritise vaccine boosters for vulnerable immunocompromised patients and prevent emergence of new COVID variants, say scientists

California's most economically and culturally important species among those most vulnerable to projected climate change

Scientists develop novel self-healing electronic skin for health monitoring

Models show intensifying wildfires in a warming world due to changes in vegetation and humidity; only a minor role for lightning

Unraveling the complex role of climate in dengue dynamics

INSEAD celebrates five years of impact in North America during its second Americas Conference 2025

[Press-News.org] UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy
Using a novel strategy, team finds tumors that can be imaged by FAC PET

UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: